Why Select Medical (SEM) is a Top Value Stock for the Long-Term

Select Medical (SEM) is highlighted as a potentially attractive value stock, currently holding a Zacks Rank of #3 (Hold) but boasting a Value Style Score of A due to a forward P/E ratio of 13.47. The article notes one analyst revision upward for fiscal year 2025 and an average earnings surprise of 8.3%, suggesting potential upside for value investors despite the neutral Zacks Rank.

Analysis

Select Medical (SEM) is currently rated as a #3 (Hold) by Zacks, yet it exhibits strong value characteristics, meriting a Value Style Score of A and a VGM Score of B. This favorable value assessment is underpinned by an attractive forward P/E ratio of 13.47, suggesting the stock may be undervalued relative to its earnings potential. While one analyst has revised their fiscal 2025 earnings estimate upwards in the past 60 days, the Zacks Consensus Estimate for fiscal 2025 earnings per share has remained unchanged at $1.14. Historically, SEM has demonstrated an ability to outperform expectations, boasting an average earnings surprise of 8.3%. These factors collectively indicate that despite a neutral overall rank, SEM presents compelling attributes for value-focused investors, primarily driven by its valuation metrics and consistent earnings beats, though the lack of movement in consensus earnings estimates warrants attention.

Key Decisions for Investors

• Value-oriented investors may consider SEM an attractive candidate due to its 'A' Value Style Score and a forward P/E of 13.47, despite its current Zacks #3 (Hold) rank.
• Investors should closely monitor future analyst earnings estimate revisions and any changes to the Zacks Consensus Estimate for fiscal 2025, as the single recent upward revision has not yet impacted the overall consensus.
• While the average earnings surprise of 8.3% is positive, the 'Hold' rating suggests a cautious approach; investors should weigh the strong value metrics against the neutral broader outlook and conduct thorough due diligence.